25 Recruiting Trials

Clinical Trials
for Diabetes in New Jersey

25 clinical trials for Diabetes are currently recruiting participants at study sites in New Jersey. Study-related care is provided at no cost.

25
Recruiting trials
42
Study sites
24
Cities
16
Industry-sponsored
5
Phase 2
10
Phase 3

Diabetes clinical trials in New Jersey: what to expect

Diabetes is one of the largest areas of clinical research, and the trials differ a great deal by type. Type 2 studies most often test new glucose-lowering or weight-reducing medicines, once-weekly insulins, and combinations with GLP-1 drugs, in people whose A1c is above goal on their current treatment. Type 1 studies test automated insulin delivery systems, immune therapies for people recently diagnosed or at high risk, and cell-based approaches. Others focus on the complications: kidney disease, eye disease, nerve pain and foot ulcers.

In New Jersey, recruiting diabetes studies are concentrated in New Brunswick, Somerset, Warren Township and Basking Ridge, with sites in 20 other cities. 16 of the 25 are run by a drug or device company, which usually means a larger study with travel reimbursement; the rest are academic or hospital-led.

Who diabetes trials usually look for

Type 2 trials typically ask for a confirmed diagnosis, an A1c in a stated range (often between 7 and 10.5 percent) and a stable dose of your current medicines for at least a few months. Many exclude recent insulin use, a recent heart attack or stroke, or kidney function below a cut-off. Type 1 trials are often limited by time since diagnosis and by age, and some enroll children and teenagers with a parent's consent.

You do not need to know your A1c or kidney numbers to ask about a trial; the site measures them at screening.

What taking part involves

Screening includes blood work and a review of your history. Medicine trials usually last six months to three years with visits every one to three months, and many provide a glucose monitor and supplies for the duration. Some compare a new drug with a standard one rather than a placebo, so everyone receives active treatment; others include a placebo arm, and the consent form says which. Study drugs, devices, visits and labs are provided at no cost, and most trials pay for time and travel.

Questions worth asking the study team

Whether you would stay on your current medicines; whether there is a placebo group; how often visits are and whether any can be done remotely; and whether your own doctor will receive the results of study labs. If you have type 1 diabetes, ask whether the study uses your own pump or monitor.

Showing 20 of 25 recruiting Diabetes trials in New Jersey

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
PHASE3 Anniston, Alabama +4 sites NCT07064473
This trial is looking for adults with type 2 diabetes, high blood pressure, and heart disease. Participants will take either the study medication or a placebo daily for up to 4 years.
Recruiting
Clinical Application of Stem Cell Educator Therapy in Type 1 Diabetes
PHASE3 Paramus, New Jersey +1 sites NCT04011020
This trial is looking for people with type 1 diabetes. Participants will have their own immune cells treated with stem cells to help manage their condition better.
Recruiting
Exercise and Intranasal Insulin in Type 2 Diabetes
PHASE2 New Brunswick, New Jersey +3 sites NCT07675499
This trial is looking for adults aged 55 to 80 with type 2 diabetes. Participants will engage in regular exercise and use a nose spray that contains insulin to see how it affects thinking and memory.
Recruiting
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
PHASE2 Phoenix, Arizona +4 sites NCT06897475
This trial is looking for adults with type 2 diabetes who have certain blood sugar levels and are managing their condition with specific injectable medications. They should also have maintained their weight for a few months and not have serious heart issues or other specific health conditions. However, it’s important that they haven’t recently used any weight loss medications or insulin.
Recruiting
A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
PHASE2 Birmingham, Alabama +4 sites NCT07340320
This trial is looking for adults with type 2 diabetes who aren't able to control their blood sugar well while taking metformin. Participants will receive either the new medication CX11 or a placebo for 24 weeks, followed by a 2-week follow-up.
Recruiting
Virtual Diabetes Care for Adults With Type 2 Diabetes on Medicaid and Insulin Therapy
NA New Brunswick, New Jersey +1 sites NCT06814184
This trial is looking for adults with type 2 diabetes who are on insulin therapy and use a smartphone. Participants will use an app and messaging to help manage their diabetes over 12 months.
Recruiting
Extracellular Vesicles, Insulin Action, and Exercise
NA New Brunswick, New Jersey +2 sites NCT06546085
This trial is looking for adults aged 30 to 80 with type 2 diabetes or obesity. Participants will help researchers understand how extracellular vesicles impact blood flow and metabolic health, and whether exercise can make a difference.
Recruiting
CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes
NA Sewell, New Jersey +1 sites NCT07184775
This trial is looking for pregnant women with type 2 diabetes. Participants will use either a fingerstick method or a continuous glucose monitor to check their blood sugar levels during pregnancy.
Recruiting
Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
NA Dothan, Alabama +4 sites NCT06190717
This trial is looking for adult patients with severe kidney disease who need to create a specific type of access for dialysis. Participants will undergo regular ultrasound assessments to help with the process.
Recruiting
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
NA Chandler, Arizona +4 sites NCT06112418
This trial is looking for older adults with diabetes or risk factors for heart disease. Participants will be randomly assigned to receive different types of care to see which approach is better at preventing heart problems.
Recruiting
Single vs Multi-Dose Insulin for Glycemic Control (SUGAR)
NA New Brunswick, New Jersey +1 sites NCT07171684
This trial is looking for pregnant women with diabetes who need insulin. Participants will take one daily dose of long-acting insulin and keep track of their blood sugar levels each week.
Recruiting
Enhancing Preventative Health Behaviors Among Emergency Department Hyperglycemic Patients
NA New Brunswick, New Jersey +1 sites NCT06663813
This trial is looking for adults who come to the Emergency Department with high blood sugar. Participants will receive health education and fill out surveys to help understand how this affects their health behaviors.
Recruiting
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
PHASE3 Gilbert, Arizona +4 sites NCT07684144
This trial is looking for people with obesity and type 2 diabetes who have completed a previous study. Participants will take a medication to see how it works over a longer time period, while following specific rules during the trial.
Recruiting
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
PHASE3 Escondido, California +4 sites NCT07776509
This trial is looking for adults with obesity or overweight who have related health problems. Participants will take a medication called AZD6234 and will be compared to others taking a placebo over 68 weeks.
Recruiting
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
PHASE3 Fairhope, Alabama +4 sites NCT07784270
This trial is looking for adults with type 2 diabetes and obesity or being overweight. Participants will take AZD6234 or a placebo for 68 weeks to see how it affects their body weight.
Recruiting
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
PHASE3 Birmingham, Alabama +4 sites NCT07743450
This trial is looking for adults with obesity or overweight who have type 2 diabetes. Participants will take a daily oral medication to see how well it works and how safe it is over time.
Recruiting
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
PHASE2 Gilbert, Arizona +4 sites NCT07215559
This trial is looking for adults who are overweight or have obesity and have type 2 diabetes. Participation will last about 48 weeks and involves taking the study medications to help with weight loss.
Recruiting
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
PHASE3 Birmingham, Alabama +4 sites NCT07282600
This trial is looking for people with obesity or overweight who also have type 2 diabetes. Participants will take eloralintide or a placebo for about 75 weeks to see if it helps with weight loss.
Recruiting
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
PHASE3 Tuscaloosa, Alabama +4 sites NCT07321886
This trial is looking for adults who are overweight or have obesity but do not have type 2 diabetes. Participants will take eloralintide for a main phase lasting about 75 weeks, with an option to continue for another 2 years if they have prediabetes.
Recruiting
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
PHASE3 Dothan, Alabama +4 sites NCT07784725
This trial is looking for adults with obesity or overweight who have tried to lose weight before. Participants will take AZD6234 or a placebo for 68 weeks to see how it affects weight change.
Recruiting

Where the Diabetes studies are in New Jersey

  • IMA Clinical Research Warren, Warren Township2 trials
  • Institute for Food, Nutrition, and Health, New Brunswick2 trials
  • Premier Research, Trenton2 trials
  • Research Site, Somerset2 trials
  • Robert Wood Johnson University Hospital Clinical Research Center, New Brunswick2 trials
  • Rutgers University Loree Gymnasium, New Brunswick2 trials

Counts are recruiting studies listing at least one site in New Jersey, from ClinicalTrials.gov, refreshed every two days.

Diabetes clinical trials in New Jersey: common questions

How many Diabetes clinical trials are recruiting in New Jersey?
TrialFinder currently lists 25 recruiting Diabetes clinical trials with study sites in New Jersey. Results are updated regularly from ClinicalTrials.gov, the official U.S. registry of clinical studies.
Where are Diabetes clinical trials located in New Jersey?
Study sites for the Diabetes trials listed on this page include Paramus, New Brunswick, Sewell. Each trial page lists every participating site with contact details, so you can find the location closest to you.
Do I need insurance to join a Diabetes clinical trial in New Jersey?
No. Study-related care is covered by the trial sponsor at no cost to participants, including the study treatment, required lab tests and study visits. Many Diabetes trials in New Jersey also compensate participants for time and travel. Health insurance is not required to search or enroll.
How do I qualify for a Diabetes clinical trial in New Jersey?
Each study sets its own criteria based on age, Diabetes diagnosis details, prior treatments, current medications and general health. The fastest way to find out is to contact a research site directly — most will pre-screen you by phone in 10 to 15 minutes at no charge. You can also create a free TrialFinder profile to be matched automatically.
Can I join a diabetes clinical trial if I am already on medication?
Usually yes. Most type 2 diabetes trials enroll people on metformin or other oral medicines and test a new treatment on top of them; some require a stable dose for a few months first. Trials that exclude insulin or a specific drug say so in their criteria.
Do I need to know my A1c to apply?
No. Trials state an A1c range, but the study site measures it at the screening visit. You only need to know that you have been diagnosed and which type.
Are Clinical Trials Safe? What Patients Should Know
How clinical trial safety works — phases, IRB oversight, informed consent, and your right to withdraw — plus the real risks and questions to ask.
How to Know If You Qualify for a Clinical Trial
Every trial has eligibility criteria based on diagnosis, age, and medical history. Here's how to tell if you qualify — and what to do if you're not sure.
Clinical Trials Without Insurance: What You Need to Know
Clinical trials cover the cost of study-related care, making them one of the few ways to access treatment without health insurance. Here's what's covered.
All guides →

Check Your Eligibility

Create a free profile and our AI will match you to Diabetes trials near you in New Jersey.

Get Matched — Free
No insurance required

Diabetes clinical trials study new treatments for Type 1, Type 2, and gestational diabetes, including insulin therapies, diet interventions, and islet-cell transplants.

All Diabetes trials →